86* Lung function improvement with aztreonam 75 mg powder and solvent for nebuliser solution (AZLI) in a single-arm extension of a randomized trial of inhaled antipseudomonal antibiotics in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa infection
B.M. Assael, R. Chiron, R. Fischer, M. Bresnik, S. Lewis, A.B. Montgomery, T. PresslerVolume:
10
Year:
2011
Language:
english
DOI:
10.1016/s1569-1993(11)60104-5
File:
PDF, 51 KB
english, 2011